Retrophin (RTRX) Tops Q1 EPS by 27c

Retrophin (NASDAQ: RTRX) reported Q1 EPS of $0.01, $0.27 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $33.6 million versus the consensus estimate of $36.2 million.

For earnings history and earnings-related data on Retrophin (RTRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c